Virios Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/18/2024
Virios Therapeutics Stock Forecast and Price Target
The average price target for Virios Therapeutics's stock set by recognized analysts recently is $2.20, which would result in a potential upside of approximately 528.57% if it reached this mark. The estimation is based on a high estimate of $4.00 and a low estimate of $0.40.
528.57% Upside
Virios Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Virios Therapeutics's Price has grown, increasing from $0.00 to $0.00 – an increase of 100.00%. For next year, the 0 analysts predict Fair Value of $0.00, which would mean an increase of 100.00%. Over the next six years, the pros' prediction is Fair Valueof $0.00, which would mean a six-year growth forecast of 100.00%.
Virios Therapeutics EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Virios Therapeutics has seen a decline in its EBIT, from $-10.01M to $-5.45M – a 45.55% decrease. Next year, analysts are expecting EBIT to reach $-7.58M – an increase of 39.00%. Over the next seven years, the forecast is for EBIT to grow by 103.70%.
Virios Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Virios Therapeutics's EPS has grown, increasing from $-1.92 to $0.00 – an increase of 100.00%. For next year, the 0 analysts predict EPS of $0.00, which would mean an increase of 100.00%. Over the next six years, the pros' prediction is EPSof $0.00, which would mean a six-year growth forecast of 100.00%.